Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001062993-15-005302
Filing Date
2015-10-07
Accepted
2015-10-06 21:24:38
Documents
2
Period of Report
2015-10-01
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A form8ka.htm 8-K/A 13744
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 5278
  Complete submission text file 0001062993-15-005302.txt   20555
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K/A | Act: 34 | File No.: 000-51652 | Film No.: 151147633
SIC: 8731 Services-Commercial Physical & Biological Research